Immunex Corporation's P2P Acquisition

Immunex Corporation raised a round of funding on December 16, 2001. Investors include Amgen.

Immunex Corporation is focused on products for rheumatoid arthritis, acute nonlymphocytic leukemia and pain.…

Articles about Immunex Corporation's P2P Acquisition: